Ajanta Pharma Ltd.
| BSE: 532331 | Sector: Health care |
| NSE: AJANTPHARM | ISIN Code: INE031B01049 |
| BSE 11:56 | 16 May | 1712.70 |
1.65 (0.10%) |
OPEN
1884.40 |
HIGH
1884.40 |
LOW
1700.40 |
| NSE 11:39 | 16 May | 1710.40 |
-2.65 (-0.15%) |
OPEN
1722.10 |
HIGH
1723.00 |
LOW
1699.05 |
| OPEN | 1884.40 |
| PREVIOUS CLOSE | 1711.05 |
| VOLUME | 621 |
| 52-Week high | 2420.00 |
| 52-Week low | 1593.30 |
| P/E | 20.32 |
| Mkt Cap.(Rs cr) | 14,626 |
| Buy Price | 1713.45 |
| Buy Qty | 1.00 |
| Sell Price | 1715.85 |
| Sell Qty | 1.00 |
Ajanta Pharma Ltd. (AJANTPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 550.15 | -12.00 | -2.13 | 15823.68 |
| Cipla | 936.90 | 4.05 | 0.43 | 13900.58 |
| Dr Reddy's Labs | 3873.10 | -50.40 | -1.28 | 13349.10 |
| Sun Pharma.Inds. | 889.65 | 7.55 | 0.86 | 12803.21 |
| Lupin | 684.05 | -12.25 | -1.76 | 11055.93 |
| Apollo Hospitals | 3645.10 | 96.90 | 2.73 | 9153.00 |
| Zydus Lifesci. | 343.10 | 2.40 | 0.70 | 7790.40 |
| Glenmark Pharma. | 391.30 | -2.75 | -0.70 | 7567.93 |
| Alkem Lab | 2888.00 | -15.00 | -0.52 | 7219.68 |
| Divi's Lab. | 4247.40 | -36.35 | -0.85 | 6798.61 |
| Torrent Pharma. | 2605.15 | 23.80 | 0.92 | 6450.83 |
| Ipca Labs. | 982.60 | 7.65 | 0.78 | 5114.11 |
| Alembic Pharma | 745.55 | 4.10 | 0.55 | 5051.44 |
| Laurus Labs | 536.10 | -2.35 | -0.44 | 4768.72 |
| Abbott India | 16508.65 | -33.75 | -0.20 | 4310.02 |
| Gland Pharma | 3080.15 | 84.75 | 2.83 | 3462.88 |
| Glaxosmi. Pharma | 1503.60 | 11.95 | 0.80 | 3193.74 |
| Granules India | 240.60 | 1.35 | 0.56 | 3134.98 |
| Sanofi India | 6634.55 | -113.95 | -1.69 | 2956.60 |
| Ajanta Pharma | 1712.70 | 1.65 | 0.10 | 2718.59 |
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
